Multi-omics analyses

OTHER2 trials

Sponsors

Azienda Ospedaliero-Universitaria di Parma

Conditions

Acute LeukemiaBladder CancerChronic LeukemiaLymphoproliferative DisordersMelanomaMultiple MyelomaMyelodysplastic DisordersMyeloma Multiple

Unknown Phase

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

RecruitingNCT07403630

Azienda Ospedaliero-Universitaria di ParmaAcute Leukemia, Bladder Cancer, Chronic Leukemia +9

Start: 2023-05-31End: 2028-02-12Target: 300Updated: 2026-02-17

Feasibility of a Multi-omics Platform for Hematological Malignancies

RecruitingNCT07445438

Azienda Ospedaliero-Universitaria di ParmaAcute Leukemia, Chronic Leukemia, Lymphoproliferative Disorders +3

Start: 2025-03-31End: 2030-03-01Target: 1040Updated: 2026-03-03